Author

R. C. Rostomily

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. D. Rodriguez· 2 shared A. Folch· 2 shared K. Castro· 2 shared L. F. Horowitz· 2 shared R. J. Monnat· 2 shared A. Korkut· 1 shared A. Mikheev· 1 shared A. Raman· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. D. Rodriguez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A prognostic matrix code defines functional glioblastoma phenotypes and niches.

M. Vishnoi, Z. Dereli, Z. Yin, E. K. Kong, M. Kinali, K. Thapa, O. Babur, K. Yun, N. H. Abdelfattah, X. Li, B. Bozorgui, R. C. Rostomily, A. Korkut

This paper identifies a matrix code based on extracellular core matrix proteins that categorizes glioblastoma tumors into prognostic groups and predicts responses to PD1 blockade.

bioRxiv · Jun 6, 2023 · PreprintCancer Biology

A Microfluidic Platform for Functional Testing of Cancer Drugs on Intact Tumor Slices

A. D. Rodriguez, L. F. Horowitz, K. Castro, H. Kenerson, N. Bhattacharjee, G. Gandhe, A. Raman, R. J. Monnat, R. S. Yeung, R. C. Rostomily, A. Folch

This paper develops a microfluidic platform for testing cancer drugs on intact tumor slices to improve drug response assessment in precision oncology.

bioRxiv · Mar 2, 2020Bioengineering

Multiplexed drug testing of tumor slices using a microfluidic platform

L. F. Horowitz, A. D. Rodriguez, Z. Dereli-Korkut, R. Lin, K. Castro, A. Mikheev, R. J. Monnat, A. Folch, R. C. Rostomily

This paper develops a microfluidic platform for rapid, multiplexed drug testing of cancer slices to guide personalized therapy.

bioRxiv · Feb 25, 2020Bioengineering